Vaccines-2013 - OMICS Group

September2 nd International Conference onClinical Microbiology-2013132 nd OMICS Group ConferenceClinical Microbiology & Microbial GenomicsHampton Inn Tropicana, Las Vegas, NV, USA September 16-18, 2013Theme: “To Encompass Emerging Trends in Clinical Microbiology”OMICS Group is proud to announce 2 nd International Conference on Clinical Microbiology & Microbial Genomics which is going to beheld in Las Vegas, USA during September 16-18, 2013. The event will focus in particular on microbial infections, toxins, novel diagnosticsand treatment in the field of Clinical Microbiology. This event will provide an unique platform for clinical scientists, young researchers, andconsultants in clinical and medical microbiology to exchange current information, emphasize on the molecular basis of microbial infection,host-pathogenic interactions and control of microbial contamination. Clinical Microbiology-2013 designed with multiple sessions includesscientific lectures, oral contributions, plenary meetings and parallel sessions with eminent scientists, poster sessions, workshops, spotlightpresentations, case studies, industry updates and instruments/manufacturers exhibition.www.omicsgroup.com/conferences/clinicalmicrobiology-2013Scientific TracksTrack 1: Novel Insights into Clinical MicrobiologyTrack 1-1 Broad spectrum antibiotics and current developmentTrack 1-2 Liver infections: Diagnosis of hepatitis and controlTrack 1-3 Gastrointestinal and urinary tract infectionsTrack 1-4 Septic arthritis and osteomyelitisTrack 1-5 Sexually transmitted infectionsTrack 1-6 Clinical parasitologyTrack 1-7 Fungal infections and anti-fungal therapeuticsTrack 1-8 Antiviral drugs and viral resistanceTrack 1-9 Microbial food poisoning and therapeuticsTrack 2: Microbiology- Current ResearchTrack 2-1 Advancements in pharmaceutical microbiologyTrack 2-2 Applied and environmental microbiologyTrack 2-3 Microbial metabolism and geneticsTrack 2-4 Food microbiology and safetyTrack 2-5 Hematological malignanciesTrack 2-6 Nanopatches and nanovaccinationTrack 3: Antimicrobials and DisinfectantsTrack 3-1 Bacteriocins and their significanceTrack 3-2 Microbial resistance and surveillance to disinfectantsTrack 3-3 Clinical disinfectantsTrack 3-4 Anti-microbial coatingsTrack 3-5 Plasmids and bacterial resistance to biocidsTrack 3-6 Quaternary ammonium compounds against bacteriaTrack 3-7 Natural vs. synthetic antimicrobialsTrack 4: Infection Control and ImmunityTrack 4-1 Host pathogen interactionsTrack 4-2 Immune mechanism in microbial infectionsTrack 4-3 Immunity: Response, evasion, and toleranceTrack 4-4 Immune mechanisms in pediatrics and geriatricsTrack 4-5 Tuberculosis and its controlTrack 4-6 Travel medicine, tropical and parasitic diseasesTrack 5: Clinical Infectious DiseasesTrack 5-1 Infection in the immune compromised host and transplant recepientsTrack 5-2 Community-acquired infections including CAP, sepsisTrack 5-3 Pediatric infectionsTrack 5-4 Lyme borreliosis, and toxoplasmosisTrack 5-5 Contributions of imaging techniques in hydatidosisTrack 5-6 Bacterial and fungal skin infectionsTrack 5-7 Diabetic foot infectionsTrack 5-8 Case studies in clinical microbiologyTrack 6: Tools and Diagnostics in Clinical MicrobiologyTrack 6-1 Recent trends in detection of microbial toxinsTrack 6-2 Clinical epidemiology and case studiesTrack 6-3 Biomarker tools in microbial diagnosisTrack 6-4 Nanotechnology in microbial and viral detectionTrack 6-5 Methods for antibacterial susceptibility testingTrack 6-6 Bacterial biochemical physiologyTrack 6-7 Pathogenesis and modern control methodologiesTrack 7: Clinical Veterinary Microbiology and Current ResearchTrack 7-1 Zoonoses and controlTrack 7-2 Madcow diseaseTrack 7-3 MycobacteriosisTrack 7-4 Monkey pox virusTrack 7-5 Sheep, goatpox and swineflu virusesTrack 7-6 Veterinary pathologyTrack 8: Infectious Diseases and Public HealthTrack 8-1 Vector-borne zoonoses: Chagas diseases and malariaTrack 8-2 Infections arboviruses: Yellow fever and dengueTrack 8-3 Public health and community-acquired infectionsTrack 8-4 Emerging infectious diseasesTrack 8-5 Disaster management and preventive medicineTrack 8-6 Tropical infections: DracunculiasisTrack 9: Current Research in Medical MicrobiologyTrack 9-1 Antiretroviral therapy and current research on HIV/AIDSTrack 9-2 Rabies and genome researchTrack 9-3 Eradication of polio: VaccinationTrack 9-4 Clinical importance of probioticsTrack 10: Microbial Genomics and Cellular MicrobiologyTrack 10-1 Bioinformatics: Sequence and genome analysisTrack 10-2 Microbial functional genomicsTrack 10-3 Microarray expression analysisTrack 10-4 Single cell genomics and proteomicsTrack 10-5 MetagenomicsTrack 10-6 Comparitive genomicsTrack 10-7 Microbial evolution and phylogeneticsTrack 10-8 Microbial geneticsTrack 10-9 Genome evolution and environmental genomicsTrack 11: Vaccines against Infectious DiseasesTrack 11-1 Vaccines against parasite infectionsTrack 11-2 Antiviral and antibacterial vaccinesTrack 11-3 Biodefense vaccines: The filovirus experienceTrack 11-4 Plant and animal based vaccinesTrack 11-5 Rotavirus vaccinesTrack 11-6 Pneumococcal vaccinesTrack 11-7 Emerging and re-emerging infectious disease vaccinesTrack 11-8 Food safety vaccines, glyco-conjugate vaccinesTrack 11-9 Challenges in pediatric vaccinationTrack 12: Microbial and Biochemical TechnologyTrack 12-1 Industrial microbiologyTrack 12-2 Applications of biotechnology for bio-based ProductsTrack 12-3 Microbial engineering for production of chemicals and pharmaceuticalsTrack 12-4 Industrial biochemical engineeringTrack 12-5 New approaches to enzyme and microbial technologyTrack 12-6 Bacterial bioremediationTrack 12-7 Biotechnology and liquid biofuel productionSymposiumClinical Microbiology-2012 ReportThe International Conference on Clinical Microbiology & Microbial Genomics was held on November12-14, 2012 in San Antonio, USA. Clinical Microbiology-2012 created new ideas, innovative approaches, andadvanced technologies in the fi eld of Microbiology with the theme “Exploring New Territories to Fight MicrobialResistance”. All accepted abstracts have been indexed in Journal of Clinical Microbiology as a special issue.With the huge response received from scientifi c fraternity, renowned personalities and Editorial BoardMembers of OMICS Group across the world, we would like to announce “2 nd International Conference onClinical Microbiology & Microbial Genomics” to be held in Las Vegas, USA on September 16-18, 2013.Page 14